Prostate Cancer
PETRANHA
A Multi-arm, Open-label Phase I/IIa Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of AZD5305 in Combination with New Hormonal Agents in Patients with Metastatic Prostate Cancer (PETRANHA)
Trial overview
Clinical Area
Medical Oncology
Disease / Condition
Prostate
Study Phase
I/IIa
Trial Identifiers
Registration number: NCT05367440
GenesisCare Location(s)
Principal Investigator(s)